Device type · OCC
Respiratory Virus Panel Nucleic Acid Assay System
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
OCC
Microbiology
Device class
Class II
FDA decisions since 2015
45
510(k), De Novo and PMA
Adverse event reports
1
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Respiratory Virus Panel Nucleic Acid Assay System
- Product code
- OCC
- Device class
- Class II
- Review panel
- Microbiology
- Regulation
- 21 CFR 866.3980
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for OCC
Latest FDA decisions
The 8 newest of 45 since 2015.
K262789 · Decided Nov 4, 2026 · 90 days after receipt
Device type: Respiratory Virus Panel Nucleic Acid Assay System (OCC) · Laboratory Medicine & Pathology
- DASH Flu A/B Test510(k)
K261347 · Decided Oct 21, 2026 · 180 days after receipt
Device type: Respiratory Virus Panel Nucleic Acid Assay System (OCC) · Laboratory Medicine & Pathology
Abbott Diagnostics Scarborough, Inc.
K262747 · Decided Aug 31, 2026 · 28 days after receipt
Device type: Respiratory Virus Panel Nucleic Acid Assay System (OCC) · Laboratory Medicine & Pathology
K254139 · Decided May 1, 2026 · 130 days after receipt
Device type: Respiratory Virus Panel Nucleic Acid Assay System (OCC) · Laboratory Medicine & Pathology
Luminex Molecular Diagnostics, Inc.
K242613 · Decided Oct 2, 2024 · 29 days after receipt
Device type: Respiratory Virus Panel Nucleic Acid Assay System (OCC) · Laboratory Medicine & Pathology
- ID NOW Influenza A & B 2510(k)
Abbott Diagnostics Scarborough, Inc.
K232775 · Decided Oct 10, 2023 · 29 days after receipt
Device type: Respiratory Virus Panel Nucleic Acid Assay System (OCC) · Laboratory Medicine & Pathology
K231017 · Decided May 5, 2023 · 25 days after receipt
Device type: Respiratory Virus Panel Nucleic Acid Assay System (OCC) · Laboratory Medicine & Pathology
K213822 · Decided Jul 6, 2022 · 210 days after receipt
Device type: Respiratory Virus Panel Nucleic Acid Assay System (OCC) · Laboratory Medicine & Pathology
Reports received
1
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
0
0.0% of reports
Injury reports
1
100% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 0 | 0 | 0 |
| Jan 24 | 0 | 0 | 0 | 0 |
| Feb 24 | 0 | 0 | 0 | 0 |
| Mar 24 | 0 | 0 | 0 | 0 |
| Apr 24 | 0 | 0 | 0 | 0 |
| May 24 | 1 | 0 | 0 | 0 |
| Jun 24 | 0 | 0 | 0 | 0 |
| Jul 24 | 0 | 1 | 0 | 0 |
| Aug 24 | 0 | 0 | 0 | 0 |
| Sep 24 | 0 | 0 | 0 | 0 |
| Oct 24 | 1 | 0 | 0 | 0 |
| Nov 24 | 0 | 0 | 0 | 0 |
| Dec 24 | 0 | 0 | 0 | 0 |
| Jan 25 | 0 | 0 | 0 | 0 |
| Feb 25 | 0 | 0 | 0 | 0 |
| Mar 25 | 1 | 0 | 0 | 0 |
| Apr 25 | 0 | 0 | 0 | 0 |
| May 25 | 0 | 0 | 0 | 0 |
| Jun 25 | 0 | 0 | 0 | 0 |
| Jul 25 | 0 | 0 | 0 | 0 |
| Aug 25 | 0 | 0 | 0 | 0 |
| Sep 25 | 1 | 0 | 0 | 0 |
| Oct 25 | 0 | 0 | 0 | 0 |
| Nov 25 | 0 | 0 | 0 | 0 |
| Dec 25 | 0 | 0 | 0 | 0 |
| Jan 26 | 0 | 0 | 0 | 0 |
| Feb 26 | 0 | 0 | 0 | 0 |
| Mar 26 | 0 | 0 | 0 | 0 |
| Apr 26 | 0 | 0 | 0 | 0 |
| May 26 | 0 | 0 | 0 | 0 |
| Jun 26 | 0 | 0 | 0 | 0 |
| Jul 26 | 0 | 1 | 0 | 0 |
| Aug 26 | 0 | 0 | 0 | 0 |
| Sep 26 | 0 | 0 | 0 | 0 |
| Oct 26 | 0 | 0 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- False Negative Result1
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions1
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1877-2025 · Started Apr 30, 2025 · Posted by FDA May 29, 2025
Reason given: Due to manufacturing error, respiratory panel may result in elevated control failures and/or false negative results.
Cause as FDA categorized it: Under Investigation by firm
Abbott Diagnostics Scarborough, Inc.
Z-1573-2025 · Started Mar 4, 2025 · Posted by FDA Apr 15, 2025
Reason given: The impacted lots have a higher occurrence of invalid rates when compared to the product Instructions for Use.
Cause as FDA categorized it: Process change control
Abbott Diagnostics Scarborough, Inc.
Z-1576-2025 · Started Mar 4, 2025 · Posted by FDA Apr 15, 2025
Reason given: the impacted lots have a higher occurrence of invalid rates when compared to the product Instructions for Use.
Cause as FDA categorized it: Process change control
- NxTAG Respiratory Pathogen Panel, REF: I051C0447Open, Classified
Luminex Molecular Diagnostics Inc
Z-0042-2025 · Started Sep 5, 2024 · Posted by FDA Oct 9, 2024
Reason given: Respiratory pathogen panel may report an elevated rate (7.6% predicted probability of occurrence) of non-specific hMPV target (human Metapneumovirus) results, risk identified predominantly in clinical samples that present positivity for another target, leading to an erroneous co-infection result, can potentially...
Cause as FDA categorized it: Device Design
Z-3123-2024 · Started Aug 7, 2024 · Posted by FDA Sep 11, 2024
Reason given: Some automated in vitro diagnostic modules and instruments manufactured or serviced between May 2022 and May 2024 were calibrated with internal equipment that may lead modules and instruments to report higher melting temperatures, which may lead to erroneous results including false positive Salmonella, Giardia...
Cause as FDA categorized it: Under Investigation by firm
- Simplexa Flu A/B & RSV Direct Gen II, REF: MOL2655; including Reaction Mix REF: MOL2656; with previous assay definition v5.Open, Classified
Z-1210-2023 · Started Jan 30, 2023 · Posted by FDA Mar 3, 2023
Reason given: Direct amplification Discs , used with COVID-19 and Flu A/B & RSV assays, may leak and cause contamination, cross-contamination, invalid results, and error codes.
Cause as FDA categorized it: Device Design
- Verigene Respiratory Pathogens Flex Nucleic Acid Test (RP Flex) Model Number: 20-006-024Open, Classified
Z-2006-2021 · Started Oct 30, 2020
Reason given: Potential for a false-negative result.
Cause as FDA categorized it: Device Design
- Verigene Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) Model Number: 20-006-018Open, Classified
Z-2007-2021 · Started Oct 30, 2020
Reason given: Potential for a false-negative result.
Cause as FDA categorized it: Device Design
Showing the 8 newest of 25 recall records in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.